✦ LIBER ✦
Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial
✍ Scribed by Barbara D. Wamil; Gary B. Thurman; Hakan W. Sundell; Russel F. DeVore; Gail Wakefield; David H. Johnson; Yue-Fen Wang; Carl G. Hellerqvist
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 703 KB
- Volume
- 123
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.